| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | -0.077 | 0.03 |
| mRNA | Obatoclax Mesylate | GDSC1000 | pan-cancer | AAC | 0.075 | 0.03 |
| mRNA | KU-55933 | GDSC1000 | pan-cancer | AAC | -0.075 | 0.03 |
| mRNA | AT13387 | CTRPv2 | pan-cancer | AAC | -0.098 | 0.03 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | 0.11 | 0.03 |
| mRNA | Epothilone B | FIMM | pan-cancer | AAC | 0.33 | 0.04 |
| mRNA | UNC0638 | CTRPv2 | pan-cancer | AAC | -0.074 | 0.04 |
| mRNA | AZ-3146 | CTRPv2 | pan-cancer | AAC | -0.071 | 0.04 |
| mRNA | ifosfamide | CTRPv2 | pan-cancer | AAC | 0.11 | 0.04 |
| mRNA | GSK-1904529A | GDSC1000 | pan-cancer | AAC | -0.068 | 0.04 |